Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
Abstract Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson’s disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopath...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7246e0b9640e48e58c03a535ba5224ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7246e0b9640e48e58c03a535ba5224ab |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7246e0b9640e48e58c03a535ba5224ab2021-12-05T12:17:25ZTranscriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels10.1038/s41531-021-00255-x2373-8057https://doaj.org/article/7246e0b9640e48e58c03a535ba5224ab2021-12-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00255-xhttps://doaj.org/toc/2373-8057Abstract Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson’s disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopathic PD (iPD) patients, LRRK2-associated PD (L2PD) patients, and healthy controls (total n = 21 cell lines), which were cultured at two different glucose concentrations (25 and 5 mM glucose). In PD patients we identified differentially expressed genes (DEGs) that were related to biological processes mainly involving the plasmatic cell membrane, the extracellular matrix, and also neuronal functions. Such pathway deregulation was largely similar in iPD or L2PD fibroblasts. Overall, the gene expression changes detected in this study were associated with PD independently of glucose concentration.Rubén Fernández-SantiagoAnna Esteve-CodinaManel FernándezFrancesc ValldeoriolaAlmudena Sanchez-GómezEsteban MuñozYaroslau ComptaEduardo TolosaMario EzquerraMaría J. MartíNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurology. Diseases of the nervous system RC346-429 Rubén Fernández-Santiago Anna Esteve-Codina Manel Fernández Francesc Valldeoriola Almudena Sanchez-Gómez Esteban Muñoz Yaroslau Compta Eduardo Tolosa Mario Ezquerra María J. Martí Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
description |
Abstract Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson’s disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopathic PD (iPD) patients, LRRK2-associated PD (L2PD) patients, and healthy controls (total n = 21 cell lines), which were cultured at two different glucose concentrations (25 and 5 mM glucose). In PD patients we identified differentially expressed genes (DEGs) that were related to biological processes mainly involving the plasmatic cell membrane, the extracellular matrix, and also neuronal functions. Such pathway deregulation was largely similar in iPD or L2PD fibroblasts. Overall, the gene expression changes detected in this study were associated with PD independently of glucose concentration. |
format |
article |
author |
Rubén Fernández-Santiago Anna Esteve-Codina Manel Fernández Francesc Valldeoriola Almudena Sanchez-Gómez Esteban Muñoz Yaroslau Compta Eduardo Tolosa Mario Ezquerra María J. Martí |
author_facet |
Rubén Fernández-Santiago Anna Esteve-Codina Manel Fernández Francesc Valldeoriola Almudena Sanchez-Gómez Esteban Muñoz Yaroslau Compta Eduardo Tolosa Mario Ezquerra María J. Martí |
author_sort |
Rubén Fernández-Santiago |
title |
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
title_short |
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
title_full |
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
title_fullStr |
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
title_full_unstemmed |
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels |
title_sort |
transcriptome analysis in lrrk2 and idiopathic parkinson’s disease at different glucose levels |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/7246e0b9640e48e58c03a535ba5224ab |
work_keys_str_mv |
AT rubenfernandezsantiago transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT annaestevecodina transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT manelfernandez transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT francescvalldeoriola transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT almudenasanchezgomez transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT estebanmunoz transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT yaroslaucompta transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT eduardotolosa transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT marioezquerra transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels AT mariajmarti transcriptomeanalysisinlrrk2andidiopathicparkinsonsdiseaseatdifferentglucoselevels |
_version_ |
1718372079177302016 |